WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2023)
Top biotech stocks in 2023 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
United States
$1.95B59,620,73162.67%37.33%Net SellingNet Selling
BNTX
BIONTECH SE
Germany
$30.02B240,993,99816.46%0.00%
DVAX
DYNAVAX TECHNOLOGIES CORP
United States
$1.25B127,686,63169.09%30.91%Net SellingNet Selling
CPRX
CATALYST PHARMACEUTICALS INC
United States
$1.75B105,654,39579.61%17.05%Net SellingNet Buying
OCUP
OCUPHIRE PHARMA INC
United States
$78.55M20,947,8301.03%98.97%Net Buying
KNSA
KINIKSA PHARMACEUTICALS LTD
Bermuda
$750.54M69,753,12343.41%9.96%Net SellingNet Selling
TBPH
THERAVANCE BIOPHARMA INC
Cayman Islands
$682.08M62,864,47466.21%33.79%Net SellingNet Selling
SELB
SELECTA BIOSCIENCES INC
United States
$213.11M153,318,91534.92%38.28%Net BuyingNet Selling
VIR
VIR BIOTECHNOLOGY INC
United States
$3.11B133,531,37961.03%38.97%Net SellingNet Selling
UTHR
UNITED THERAPEUTICS CORP
United States
$10.37B46,301,65687.61%12.39%Net SellingNet Selling
CMRX
CHIMERIX INC
United States
$111.22M88,273,56759.14%31.08%Net BuyingNet Buying
IMTX
IMMATICS NV
Germany
$529.03M76,670,69944.41%0.00%
CDMO
AVID BIOSERVICES INC
United States
$1.17B62,547,05692.37%7.63%Net SellingNet Selling
REGN
REGENERON PHARMACEUTICALS INC
United States
$89.83B109,325,53269.99%30.01%Net SellingNet Selling
MRNA
MODERNA INC
United States
$59.33B386,339,59464.14%22.31%Net SellingNet Selling
SIGA
SIGA TECHNOLOGIES INC
United States
$415.16M72,201,16933.41%66.59%Net Selling
ZYME
ZYMEWORKS INC
Canada
$578.93M64,041,28760.52%39.48%Net BuyingNet Buying
MOLN
MOLECULAR PARTNERS AG
Switzerland
$217.64M36,044,7062.55%0.00%
VRTX
VERTEX PHARMACEUTICALS INC
United States
$81.00B257,091,44191.64%1.52%Net SellingNet Selling
GMAB
GENMAB A
Denmark
$24.91B65,961,57369.29%0.00%
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
United States
$3.51B250,879,33133.93%66.07%Net SellingNet Selling
ABCL
ABCELLERA BIOLOGICS INC
Canada
$2.17B287,686,19944.27%45.83%Net BuyingNet Buying
VACC
VACCITECH PLC
United Kingdom
$85.88M38,338,76426.68%55.14%Net SellingNet Selling
GNFT
GENFIT SA
France
$204.24M49,815,4894.33%0.00%
NBIX
NEUROCRINE BIOSCIENCES INC
United States
$9.78B96,587,91169.08%30.92%Net SellingNet Selling
CGEM
CULLINAN ONCOLOGY INC
United States
$402.32M39,327,29849.04%50.96%Net BuyingNet Selling
APVO
APTEVO THERAPEUTICS INC
United States
$14.73M7,239,47113.31%50.90%
RPTX
REPARE THERAPEUTICS INC
Canada
$414.05M42,077,89659.26%40.74%Net Selling
ITOS
ITEOS THERAPEUTICS INC
United States
$486.15M35,720,40161.88%38.12%Net SellingNet Buying
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
United States
$636.53M26,555,48385.25%14.62%Net BuyingNet Selling
VCYT
VERACYTE INC
United States
$1.61B72,149,63664.34%35.66%Net SellingNet Selling
ACET
ADICET BIO INC
United States
$247.42M42,954,97573.19%26.81%Net SellingNet Selling
XENE
XENON PHARMACEUTICALS INC
Canada
$2.26B63,037,99195.84%4.03%Net SellingNet Buying
ICPT
INTERCEPT PHARMACEUTICALS INC
United States
$559.63M41,670,12049.86%50.14%Net SellingNet Selling
PULM
PULMATRIX INC
United States
$10.66M3,652,2857.87%92.13%
PGEN
PRECIGEN INC
United States
$267.33M252,194,71316.76%70.39%Net BuyingNet Buying
MORF
MORPHIC HOLDING INC
United States
$1.49B39,534,13857.76%42.24%Net BuyingNet Buying
ZLAB
ZAI LAB LTD
China
$3.26B979,087,4305.94%1.96%Net BuyingNet Buying
IDYA
IDEAYA BIOSCIENCES INC
United States
$664.36M48,387,22286.10%13.90%
VBLT
VASCULAR BIOGENICS LTD
Israel
$11.72M69,750,1173.54%8.74%
DBVT
DBV TECHNOLOGIES SA
France
$317.81M94,025,44157.15%15.63%
PPBT
PURPLE BIOTECH LTD
Israel
$33.08M184,815,0920.09%0.00%
ONTX
ONCONOVA THERAPEUTICS INC
United States
$15.33M20,969,5597.40%83.87%Net SellingNet Selling
IMRN
IMMURON LTD
Australia
$10.68M227,798,3460.04%0.00%
CRNX
CRINETICS PHARMACEUTICALS INC
United States
$865.78M53,908,86581.66%18.34%Net SellingNet Selling
XBIO
XENETIC BIOSCIENCES INC
United States
$6.16M15,166,5964.58%26.79%
BLU
BELLUS HEALTH INC
Canada
$911.28M126,567,12189.84%0.00%
LMNL
LIMINAL BIOSCIENCES INC
Canada
$117.96M31,042,5600.59%0.00%
TECH
BIO-TECHNE CORP
United States
$11.67B157,275,20095.21%2.11%Net BuyingNet Buying
OMER
OMEROS CORP
United States
$292.15M62,828,76531.04%5.93%
SRRK
SCHOLAR ROCK HOLDING CORP
United States
$415.88M51,985,07257.25%42.75%Net BuyingNet Buying
ALEC
ALECTOR INC
United States
$513.94M83,027,91053.96%46.04%Net SellingNet Selling
PTE
POLARITYTE INC
United States
$3.69M7,323,7552.16%97.84%Net SellingNet Buying
ALT
ALTIMMUNE INC
United States
$207.96M49,278,86142.67%57.33%Net SellingNet Buying
INCY
INCYTE CORP
United States
$16.11B222,965,01878.83%21.17%Net SellingNet Buying
BMRN
BIOMARIN PHARMACEUTICAL INC
United States
$18.14B186,528,78497.63%1.50%Net SellingNet Selling
SURF
SURFACE ONCOLOGY INC
United States
$42.44M60,716,87329.65%70.35%Net Selling
SLGL
SOL-GEL TECHNOLOGIES LTD
Israel
$89.74M23,129,46924.64%0.00%
ATXS
ASTRIA THERAPEUTICS INC
United States
$372.22M27,986,71862.26%37.74%Net Buying
ATRA
ATARA BIOTHERAPEUTICS INC
United States
$278.19M95,926,71192.97%7.03%Net SellingNet Selling
CWBR
COHBAR INC
United States
$5.20M2,906,9260.94%99.06%Net Buying
SILO
SILO PHARMA INC
United States
$6.63M3,158,7970.68%5.03%Net Buying
ARTL
ARTELO BIOSCIENCES INC
United States
$6.63M2,855,6884.10%29.20%Net Buying
CORT
CORCEPT THERAPEUTICS INC
United States
$2.34B107,899,31630.30%69.70%Net BuyingNet Buying
CMMB
CHEMOMAB THERAPEUTICS LTD
Israel
$17.57M220,996,2401.50%7.66%Net SellingNet Selling
VYNE
VYNE THERAPEUTICS INC
United States
$10.05M3,264,27222.22%77.78%Net BuyingNet Buying
NVIV
INVIVO THERAPEUTICS HOLDINGS CORP
United States
$3.03M2,860,4460.95%99.05%
DOMH
DOMINARI HOLDINGS INC
United States
$15.59M4,840,59712.87%78.69%Net Buying
INVA
INNOVIVA INC
United States
$766.42M68,126,08963.59%36.41%Net SellingNet Buying
VNDA
VANDA PHARMACEUTICALS INC
United States
$385.57M56,785,26458.91%41.09%Net SellingNet Selling
BEAM
BEAM THERAPEUTICS INC
United States
$2.22B72,397,63176.70%23.30%Net SellingNet Selling
TRVI
TREVI THERAPEUTICS INC
United States
$111.08M60,045,09619.11%80.89%Net BuyingNet Buying
MEIP
MEI PHARMA INC
United States
$30.52M133,260,86537.14%9.31%Net BuyingNet Buying
LSTA
LISATA THERAPEUTICS INC
United States
$25.95M7,998,3420.83%99.17%Net BuyingNet Selling
PSTX
POSEIDA THERAPEUTICS INC
United States
$266.50M86,527,20349.73%43.92%Net BuyingNet Selling
IMMP
IMMUTEP LTD
Australia
$147.72M879,295,6260.47%0.00%
ADMA
ADMA BIOLOGICS INC
United States
$735.34M222,155,62568.71%26.48%Net SellingNet Selling
SPRO
SPERO THERAPEUTICS INC
United States
$76.23M52,571,81327.05%61.72%Net SellingNet Selling
FBRX
FORTE BIOSCIENCES INC
United States
$21.22M21,007,06918.10%33.47%Net Buying
ACRS
ACLARIS THERAPEUTICS INC
United States
$539.55M66,692,96465.46%34.54%Net SellingNet Selling
PRTA
PROTHENA CORP PUBLIC LTD CO
Ireland
$2.55B52,564,43451.02%48.98%Net BuyingNet Buying
ACST
ACASTI PHARMA INC
Canada
$20.52M44,612,8310.11%20.34%
PRTC
PURETECH HEALTH PLC
United States
$834.32M287,796,5850.48%0.00%
ABIO
ARCA BIOPHARMA INC
United States
$28.68M14,410,1431.80%98.20%Net Buying
EPIX
ESSA PHARMA INC
Canada
$130.95M44,092,37472.45%27.55%Net Buying
JNCE
JOUNCE THERAPEUTICS INC
United States
$96.46M52,140,27759.53%40.47%Net BuyingNet Buying
FIXX
HOMOLOGY MEDICINES INC
United States
$59.41M57,678,43536.59%20.22%Net SellingNet Selling
AUTL
AUTOLUS THERAPEUTICS PLC
United Kingdom
$318.46M173,074,51062.34%0.00%
CGEN
COMPUGEN LTD
Israel
$60.81M86,624,64318.70%0.00%
SAGE
SAGE THERAPEUTICS INC
United States
$2.51B59,717,60869.94%30.06%Net BuyingNet Buying
IKNA
IKENA ONCOLOGY INC
United States
$125.09M36,257,49372.44%23.38%Net Buying
RNA
AVIDITY BIOSCIENCES INC
United States
$1.09B70,807,97381.46%18.54%Net BuyingNet Buying
AEZS
AETERNA ZENTARIS INC
Canada
$12.72M4,855,8760.72%0.00%
CRDF
CARDIFF ONCOLOGY INC
United States
$73.72M44,677,16917.24%34.48%Net Buying
UPC
UNIVERSE PHARMACEUTICALS INC
China
$12.66M21,750,0000.30%0.00%
AADI
AADI BIOSCIENCE INC
United States
$176.92M24,436,99030.68%69.32%Net Buying
AFMD
AFFIMED NV
Germany
$111.41M149,339,33554.11%0.00%
EXEL
EXELIXIS INC
United States
$6.29B324,087,33786.44%2.82%Net SellingNet Selling
BCYC
BICYCLE THERAPEUTICS PLC
United Kingdom
$638.55M30,021,07154.96%45.04%Net SellingNet Selling
LUMO
LUMOS PHARMA INC
United States
$27.21M8,219,29217.99%82.01%Net BuyingNet Buying

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2023?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the top biotech stock with a Zen Score of 62, which is 37 points higher than the biotech industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -32.89% over the past year, underperforming other biotech stocks by -7 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $60.50, an upside of 85.3% from Harmony Biosciences Holdings's current stock price of $32.65.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 50% have issued a Strong Buy rating, 33.33% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Dynavax Technologies (NASDAQ:DVAX)


Dynavax Technologies (NASDAQ:DVAX) is the second best biotech stock with a Zen Score of 59, which is 34 points higher than the biotech industry average of 25. It passed 19 out of 33 due diligence checks and has strong fundamentals. Dynavax Technologies has seen its stock lose -9.5% over the past year, overperforming other biotech stocks by 17 percentage points.

Dynavax Technologies has an average 1 year price target of $24.33, an upside of 148.04% from Dynavax Technologies's current stock price of $9.81.

Dynavax Technologies stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Dynavax Technologies, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biontech Se (NASDAQ:BNTX)


Biontech Se (NASDAQ:BNTX) is the third best biotech stock with a Zen Score of 59, which is 34 points higher than the biotech industry average of 25. It passed 22 out of 38 due diligence checks and has strong fundamentals. Biontech Se has seen its stock lose -26.96% over the past year, underperforming other biotech stocks by -1 percentage points.

Biontech Se has an average 1 year price target of $170.89, an upside of 37.18% from Biontech Se's current stock price of $124.57.

Biontech Se stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Biontech Se, 22.22% have issued a Strong Buy rating, 11.11% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Kineta (NASDAQ:KA)


Kineta (NASDAQ:KA) has an annual dividend yield of 302.42%, which is 262 percentage points higher than the biotech industry average of 40.89%.

Kineta's dividend payout ratio of -88.9% indicates that its high dividend yield might not be sustainable for the long-term.

2. Carisma Therapeutics (NASDAQ:CARM)


Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of 11.66%, which is -29 percentage points lower than the biotech industry average of 40.89%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.83%, which is -33 percentage points lower than the biotech industry average of 40.89%.

Siga Technologies's dividend payout ratio of 97.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.18% in the last day, and up 1.75% over the last week. Y Mabs Therapeutics was the among the top gainers in the biotechnology industry, gaining 52.28% yesterday.

Y-mAbs Therapeutics shares are trading higher after the company reported mixed Q4 financial results and filed for a $150 million mixed shelf offering.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Innoviva (NASDAQ:INVA)


Innoviva (NASDAQ:INVA) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Innoviva has a valuation score of 100, which is 71 points higher than the biotech industry average of 29. It passed 7 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -41.86% in the past year. It has underperformed other stocks in the biotech industry by -16 percentage points.

2. Vascular Biogenics (NASDAQ:VBLT)


Vascular Biogenics (NASDAQ:VBLT) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Vascular Biogenics has a valuation score of 100, which is 71 points higher than the biotech industry average of 29. It passed 7 out of 7 valuation due diligence checks.

Vascular Biogenics's stock has dropped -90.06% in the past year. It has underperformed other stocks in the biotech industry by -64 percentage points.

3. Dynavax Technologies (NASDAQ:DVAX)


Dynavax Technologies (NASDAQ:DVAX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Dynavax Technologies has a valuation score of 86, which is 57 points higher than the biotech industry average of 29. It passed 6 out of 7 valuation due diligence checks.

Dynavax Technologies's stock has dropped -9.5% in the past year. It has overperformed other stocks in the biotech industry by 17 percentage points.

Are biotech stocks a good buy now?

46.42% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 83.24% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.64x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.